PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities
PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities
Our report provides unique, actionable insights applicable to I-O drugs in five major categories: Immune Checkpoint Modulators (Monoclonal Antibodies & Small Molecules), Cellular Immunotherapies (Cytotoxic Cellular Immunotherapies & Call-Based Vaccines), Oncolytic Viruses, Peptide Vaccines, and Bispecific T-Cell Engagers – you won’t find this information elsewhere. GlobalData analyzes over 4,000 clinical trials to generate a truly unique insight. A total of 18 solid tumor types and 8 hematological cancers are covered.
The field of I-O involves development of therapies that can harness the body’s ability to generate and sustain an effective immune response against cancer. GlobalData selected I-O products based on their molecular targets and molecular types. KOLs share their enthusiasm about I-O therapies that have impacted various oncology indications.